A multicentre prospective collection of newly diagnosed glioblastoma patients in Lombardia, Italy

Neurological Sciences

Volumn 26, Issue 4, 2005, Pages 227-234

  Salmaggi, A ^a   Riva, M ^b   Silvani, A ^a   Merli, R ^c   Tomei, G ^d   Lorusso, L ^e   Russo, A ^f   Marchioni, E ^g   Imbesi, F ^h  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

^e Mellino Mellini Hospital Trust   (Italy)

^f SANT ANNA HOSPITAL   (Italy)

^g C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^h Policlinico di Monza   (Italy)

Author keywords

Glioblastoma; Prospective multicentre study; Survival

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CLOBAZAM; LAMOTRIGINE; NIMUSTINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; STEROID; TEMOZOLOMIDE; TOPIRAMATE; VALPROIC ACID;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN SURGERY; CANCER CHEMOTHERAPY; COGNITIVE DEFECT; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; DISEASE COURSE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEADACHE; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MOOD DISORDER; NEUROLOGY; NEUROSURGERY; ONCOLOGY; POPULATION RESEARCH; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; SEIZURE; SEX RATIO; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT PLANNING; VEIN THROMBOSIS;

ADULT; BRAIN; BRAIN NEOPLASMS; COHORT STUDIES; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; GEOGRAPHY; GLIOBLASTOMA; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEIZURES; SURVIVAL ANALYSIS;

EID: 26844487032     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-005-0465-y     Document Type: Article

References (25)

1. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S, and the Glioma Outcomes Investigators (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. J Neurosurg 99:467-473
2. Chang S, Parney IF, Huang W, Anderson FA, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER, for the Glioma Outcomes Project Investigators (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-564
3. Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis. Neurooncology 6:227-235
4. Surawicz TS, McCarthy BJ, Kupelian V et al (1999) Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neurooncology 1:14-25
5. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J Neurosurg 95:190-198
6. Stark M, Natavi A, Mehdorn HM, Bloemer U (2005) Glioblastoma multiforme: report of 267 cases treated at a single institution. Surg Neurol 63:162-169
7. Grant R (2004). Overview: Brain tumor diagnosis and management/Royal College of Physicians Guidelines. J Neurol Neurosurg Psychiatry 75:18-23
8. Boiardi A, Salmaggi A, Eoli M, Lamperti E, Silvani A (2004) Headache in brain tumors: A symptom to reappraise critically. Neurol Sci 25:S143-147
9. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, Gardiman M, Scienza R, Monfardini S, Ermani M (2003) A prospective study on glioblastoma in the elderly. Cancer 97:657-662
10. Dinapoli RP, Brown LD,Arusell RM, Earle JD, O'Fallon JR, Buckner JC, Scheithauer BW, Krook JE, Tschetter LK, Maier JA (1993) Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol 11:1316-1321
11. Elliott TE, Dinapoli RP, O'Fallon JR et al (1997) Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma. J Neurooncol 33:239-250
12. Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O'Fallon JR, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM (2001) A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer 92:420-433
13. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710
14. Fazeny-Doerner B, Wenzel C, Veitl M, Piribauer M, Roessler K, Dieckmann K, Ungersboeck K, Marosi C (2003) Survival and prognostic factors of patients with unresectable glioblastoma multiforme. Anti cancer Drugs 14:305-312
15. Kreth FW, Berlis A, Spiropoulou V, Faist M, Scheremet R, Rossner R, Volk B, Ostertag CB (1999) The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86:2117-2123
16. Sawaya R (1999) Extent of resection in malignant gliomas: A critical summary. J Neurooncol 42:303-305
17. Grossman SA, Batara JF (2004) Current management of glioblastoma multiforme. Semin Oncol 31:635-644
18. Glioma meta-analysis Trialists (GMT) Group (2002) Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359:1011-1018
19. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352:987-996
20. Brandes AA, Tosoni A, Amista P, Nicolardi L, Grosso D, Berti F, Ermani M (2004) How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial. Neurology 63:1281-1284
21. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain WD, Grossman SA, Cairncross JG (2000) Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology 54:1886-1893
22. Brandes AA, Scelzi E, Salmistraro G, Ermani M, Crollo C, Berti F, Zampieri P, Baiocchi C, Fiorentino MV (1997) Incidence of risk of thromboembolism during treatment of high grade gliomas: A prospective study. Eur J Cancer 33:1592-1596
23. Silvani A, Salmaggi A, Eoli M, Lamperti E, Boiardi A (2003) Venous thromboembolism in malignant glioma patients treated by chemoradiotherapy. Neurol Sci 24:272
24. Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review. Cancer 89:640-646
25. Mucacevic A, Kreth FW (2003) Quality-adjusted survival after tumor resection and/or radiation therapy for elderly patients with glioblastoma multiforme. J Neurol 250:561-568